Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blackrock Health Sciences TrustBME +0.37%39 5-Year Yield-on-Cost % is 8.63 as of Aug. 21, 2026, which is 11% above its 10-year median of 7.76. GuruFocus rates BME with a GF Score™ of 39/100. The stock has 4 warning signs investors should review. Among 1,110 Asset Management companies, Blackrock Health Sciences Trust ranks better than 65.14% on this metric.
Blackrock Health Sciences Trust (NYSE:BME) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Blackrock Health Sciences Trust 5-Year Yield-on-Cost % Related Terms
BME vs MMU, ETJ, CHW: 5-Year Yield-on-Cost % Comparison
For the Asset Management subindustry, Blackrock Health Sciences Trust's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blackrock Health Sciences Trust 5-Year Yield-on-Cost % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Blackrock Health Sciences Trust's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Blackrock Health Sciences Trust's 5-Year Yield-on-Cost % falls into.
Blackrock Health Sciences Trust 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Blackrock Health Sciences Trust (BME) has a 5-Year Yield-on-Cost % of 8.63 as of Aug. 21, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Blackrock Health Sciences Trust and its competitors. This is 11% above median its historical median of 7.76. Over the past decade, Blackrock Health Sciences Trust's 5-Year Yield-on-Cost % has ranged from 6.06 to 10.51. According to the industry distribution chart, Blackrock Health Sciences Trust ranks #387 out of 1110 companies in the Asset Management industry, placing it in the top 34.9%.
Is Blackrock Health Sciences Trust's 5-Year Yield-on-Cost % too high?
Blackrock Health Sciences Trust's current 5-Year Yield-on-Cost % of 8.63 is 11% above median its 10-year median of 7.76. Over the past 10 years, this metric has ranged from a low of 6.06 to a high of 10.51. The Asset Management industry median 5-Year Yield-on-Cost % is 6.36. Blackrock Health Sciences Trust's value of 8.63 is 35.7% above this industry median. Based on the distribution chart, Blackrock Health Sciences Trust ranks #387 out of 1110 companies in the Asset Management industry, which is above the industry midpoint. Overall, Blackrock Health Sciences Trust has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Blackrock Health Sciences Trust's 5-Year Yield-on-Cost % compare to MMU and ETJ?
According to the Asset Management industry distribution chart, Blackrock Health Sciences Trust ranks #387 out of 1110 companies for 5-Year Yield-on-Cost %. This puts Blackrock Health Sciences Trust in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 6.36. Blackrock Health Sciences Trust's value of 8.63 is 35.7% above this benchmark. Historically, Blackrock Health Sciences Trust's own 5-Year Yield-on-Cost % has ranged from 6.06 to 10.51 over the past decade. While the company's 10-year median is 7.76 vs. the industry median of 6.36, Blackrock Health Sciences Trust has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Asset Management company?
The median 5-Year Yield-on-Cost % among Asset Management companies is 6.36, based on 1,110 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blackrock Health Sciences Trust's current 5-Year Yield-on-Cost % of 8.63 is 35.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Blackrock Health Sciences Trust and its competitors. For the Asset Management industry, the median 5-Year Yield-on-Cost % is 6.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blackrock Health Sciences Trust's current 5-Year Yield-on-Cost % is 8.63, which is 11% above median its own 10-year median of 7.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blackrock Health Sciences Trust stock overvalued right now?
Blackrock Health Sciences Trust (BME) has a current 5-Year Yield-on-Cost % of 8.63. The current 5-Year Yield-on-Cost % is 8.63, which is 11% above median its 10-year median of 7.76 and 35.7% above the Asset Management industry median of 6.36. Blackrock Health Sciences Trust's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Blackrock Health Sciences Trust (BME), the current 5-Year Yield-on-Cost % is 8.63 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
39GF Score
Get the complete analysis for BME
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BME has been successfully added to your 
